2024-03-28T14:09:27Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_2DB8EE377DD2
2024-03-23T02:06:11Z
serval:BIB_2DB8EE377DD2
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
10.1016/j.jchromb.2009.04.045
19505856
000268040400002
Haouala
A.
author
Zanolari
B.
author
Rochat
B.
author
Montemurro
M.
author
Zaman
K.
author
Duchosal
M.A.
author
Ris
H.B.
author
Leyvraz
S.
author
Widmer
N.
author
Decosterd
L.A.
author
article
2009
Journal of Chromatography. B
1570-0232
journal
877
22
1982-1996
Antineoplastic Agents/blood
Antineoplastic Agents/therapeutic use
Benzenesulfonates/blood
Benzenesulfonates/therapeutic use
Chromatography, Liquid/methods
Drug Monitoring/methods
Humans
Indoles/blood
Indoles/therapeutic use
Neoplasms/drug therapy
Piperazines/blood
Piperazines/therapeutic use
Pyridines/blood
Pyridines/therapeutic use
Pyrimidines/blood
Pyrimidines/therapeutic use
Pyrroles/blood
Pyrroles/therapeutic use
Quinazolines/blood
Quinazolines/therapeutic use
Tandem Mass Spectrometry/methods
Thiazoles/blood
Thiazoles/therapeutic use
eng
60_published
peer-reviewed